ImplicitBio Profile Banner
ImplicitBioscience Profile
ImplicitBioscience

@ImplicitBio

Followers
32
Following
1
Media
2
Statuses
7

Developing groundbreaking immunotherapy treatments for serious - often fatal - diseases. Join the conversation πŸ‘‰ #implicitbioscience #IC14 #MND #ALS #Covid19

Joined February 2021
Don't wanna be here? Send us removal request.
@ImplicitBio
ImplicitBioscience
4 years
JOURNAL ARTICLE | @MedicineLWW has published a report of the first safety and biomarker study of #IC14 in patients with #ALS #MND. See it here πŸ‘‰#MedicalResearch #biotech #pharma #ImplicitBioscience
Tweet media one
0
1
1
@ImplicitBio
ImplicitBioscience
4 years
We’re proud to share a feature story written by a respected US biotechnology commentator. It captures the fascinating history of #ImplicitBioscience – including our why, how and what next – as we test the full capabilities of our IC14 antibody πŸ‘‰ #biotech.
0
1
4
@ImplicitBio
ImplicitBioscience
4 years
Did you see the @couriermail today? @janellehmiles explains how #IC14 works πŸ‘‰
0
2
7
@ImplicitBio
ImplicitBioscience
4 years
Thank you to @abcbrisbane for inviting our CSO Prof Ian Frazer into studio today for an interview with @Loretta_Ryan and @zonca (and a later cross on @abcnews 24 too) - see here πŸ‘‰
Tweet card summary image
abc.net.au
A Brisbane biotech company createsΒ an anti-inflammatory drug which is being trialled as a potential treatment for severely-ill COVID-19 patients in the United States in a bid to prevent people dying...
0
3
6
@ImplicitBio
ImplicitBioscience
4 years
Our CSO Professor Ian Frazer appeared on @sunriseon7 this morning to discuss the commencement of our Phase 2 clinical trials for #IC14 in #coronavirus patients in the US. Take a look πŸ‘‰.
0
1
2
@ImplicitBio
ImplicitBioscience
4 years
CLINICAL MILESTONE | Our lead therapeutic candidate, #IC14 will be tested as part of a Phase 2 clinical trial in COVID-19 patients in US hospitals. We're hosting a media call at @TRI_info today, learn more πŸ‘‰ @NIAIDNews #research #biotech #lifesciences
Tweet media one
0
2
6